In the last 12 months, insiders at Elicio Therapeutics, Inc. ($ELTX) filed 66 transactions with the SEC: 15 open-market purchases totaling $7,047,572 and 0 sales totaling $0. Net insider sentiment: net buying.
Elicio Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Chudnovsky Yekaterina (Not found) — 8 transactions totaling $20,338,352
- Chudnovsky Yekaterina (Director) — 3 transactions totaling $7,047,530
- DeMuth Peter (Chief Scientific Officer) — 10 transactions totaling $3,277
- Venkatesan Jay (Director) — 6 transactions totaling $505
- Venkatesan Jay (Not found) — 9 transactions totaling $20
View all SEC Filings for Elicio Therapeutics, Inc. (ELTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 50900 | $0.00 | 50,900.0000 | 17,489,516 | 9999.99% | 0.29% |
| Feb. 2, 2026 | Connelly Robert | CEO, President and Director | A | Common Stock | 73600 | $0.00 | 120,570.0000 | 17,489,516 | 156.70% | 0.42% |
| Feb. 2, 2026 | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 147200 | $0.00 | 147,200.0000 | 17,489,516 | 9999.99% | 0.84% |
| Feb. 2, 2026 | Shah Preetam | See Remarks | A | Common Stock | 24000 | $0.00 | 24,000.0000 | 17,489,516 | 9999.99% | 0.14% |
| Feb. 2, 2026 | Shah Preetam | See Remarks | A | Stock Option (Right to Buy) | 47900 | $0.00 | 47,900.0000 | 17,489,516 | 9999.99% | 0.27% |
| Feb. 2, 2026 | DeMuth Peter | Chief Scientific Officer | A | Common Stock | 20800 | $0.00 | 21,543.0000 | 17,489,516 | 2799.46% | 0.12% |
| Feb. 2, 2026 | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 41600 | $0.00 | 41,600.0000 | 17,489,516 | 9999.99% | 0.24% |
| Feb. 2, 2026 | Haqq Christopher | See Remarks | A | Common Stock | 25400 | $0.00 | 57,381.0000 | 17,489,516 | 79.42% | 0.15% |
| Dec. 9, 2025 | DeMuth Peter | Chief Scientific Officer | M | Stock Option (Right to Buy) | 362 | $0.00 | 0.0000 | 17,489,516 | 100.00% | 0.00% |
| Dec. 9, 2025 | DeMuth Peter | Chief Scientific Officer | M | Common Stock | 362 | $4.41 | 743.0000 | 17,489,516 | 95.01% | 0.00% |
| June 3, 2025 | Chudnovsky Yekaterina | Not found | A | Warrant (right to buy) | 103225 | $0.00 | 103,225.0000 | 15,953,524 | 9999.99% | 0.65% |
| May 19, 2025 | RUFFOLO ROBERT R | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | WILSON KAREN J | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | ADAMS JULIAN | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | Chudnovsky Yekaterina | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | Nissenson Allen | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | Ashe Carol Gail | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| May 19, 2025 | Venkatesan Jay | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| April 15, 2025 | Shah Preetam | See Remarks | A | Stock Option (Right to Buy) | 191624 | $0.00 | 191,624.0000 | 15,953,524 | 9999.99% | 1.20% |
| March 5, 2025 | Chudnovsky Yekaterina | Not found | C | Common Stock | 3500573 | $5.81 | 5,416,212.0000 | 0 | 182.74% | 0.00% |
| March 5, 2025 | Chudnovsky Yekaterina | Not found | C | Convertible Note (convertible into Common Stock) | 3442341 | $5.81 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 44400 | $0.00 | 44,400.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 121600 | $0.00 | 121,600.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Director | P | Common Warrants | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Director | P | Pre-Funded Warrants | 50000 | $4.99 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | DeMuth Peter | Chief Scientific Officer | M | Stock Option (Right to Buy) | 381 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 16, 2024 | DeMuth Peter | Chief Scientific Officer | M | Common Stock | 381 | $4.41 | 381.0000 | 0 | 9999.99% | 0.00% |
| Nov. 26, 2024 | Venkatesan Jay | Director | X | Warrant to Purchase Common Stock | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 26, 2024 | Venkatesan Jay | Director | X | Common Stock | 50000 | $0.01 | 180,534.0000 | 0 | 38.30% | 0.00% |
| Nov. 21, 2024 | Venkatesan Jay | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | ADAMS JULIAN | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | Nissenson Allen | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | Chudnovsky Yekaterina | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | WILSON KAREN J | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | RUFFOLO ROBERT R | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | Ashe Carol Gail | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Haqq Christopher | See Remarks | A | Stock Option (Right to Buy) | 28200 | $0.00 | 28,200.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | DeMuth Peter | Chief Scientific Officer | A | Stock Option (Right to Buy) | 29800 | $0.00 | 29,800.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Connelly Robert | CEO, President and Director | A | Stock Option (Right to Buy) | 91600 | $0.00 | 91,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | Chudnovsky Yekaterina | Not found | P | Convertible Note (convertible into Common Stock) | 3442341 | $5.81 | 3,442,341.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Pre-Funded Warrants | 50000 | $4.99 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Chudnovsky Yekaterina | Not found | P | Common Warrants | 1600000 | $0.00 | 1,600,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Chudnovsky Yekaterina | Not found | P | Pre-Funded Warrants | 1600000 | $4.99 | 1,600,000.0000 | 0 | 9999.99% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Common Warrants | 50000 | $0.00 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Pre-Funded Warrants | 50000 | $4.99 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Common Warrants | 50000 | $0.00 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Pre-Funded Warrants | 50000 | $4.99 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Common Warrants | 50000 | $0.00 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Pre-Funded Warrants | 50000 | $4.99 | 100,000.0000 | 0 | 100.00% | 0.00% |
| June 28, 2024 | Venkatesan Jay | Not found | P | Common Warrants | 50000 | $0.00 | 100,000.0000 | 0 | 100.00% | 0.00% |
| March 19, 2024 | Chudnovsky Yekaterina | Not found | P | Pre-Funded Common Stock Purchase Warrant | 1032702 | $5.81 | 1,032,702.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Piekos Brian | Chief Financial Officer | A | Stock Option (right to buy) | 43225 | $0.00 | 43,225.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | DeMuth Peter | Chief Scientific Officer | A | Stock Option (right to buy) | 342 | $0.00 | 342.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | DeMuth Peter | Chief Scientific Officer | A | Stock Option (right to buy) | 29800 | $0.00 | 29,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Haqq Christopher | See Remarks | A | Stock Option (right to buy) | 28200 | $0.00 | 28,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Connelly Robert | CEO, President and Director | A | Stock Option (right to buy) | 225137 | $0.00 | 225,137.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | WILSON KAREN J | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Nissenson Allen | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Ashe Carol Gail | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | RUFFOLO ROBERT R | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | ADAMS JULIAN | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Chudnovsky Yekaterina | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Venkatesan Jay | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 22, 2023 | Chudnovsky Yekaterina | Director | P | Common Stock | 1213000 | $5.81 | 1,915,639.0000 | 0 | 172.63% | 0.00% |
| June 1, 2023 | Piekos Brian | Chief Financial Officer | A | Stock Option (right to buy) | 75484 | $0.00 | 75,484.0000 | 0 | 9999.99% | 0.00% |